Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

CompletedOBSERVATIONAL
Enrollment

1,153

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Metastatic Brain TumorPrimary Brain TumorEpileptic/Seizure FociMovement Disorders
Interventions
DEVICE

NeuroBlate System

Trial Locations (26)

10016

New York University Langone Medical Center, New York

10029

Icahn School of Medicine at Mount Sinai, New York

15213

University of Pittsburgh Medical Center, Pittsburgh

17822

Geisinger Medical Center, Danville

27157

Wake Forest, Winston-Salem

27710

Duke University Medical Center, Durham

32804

Advent Health Orlando, Orlando

33331

The Cleveland Clinic Florida, Weston

33701

Johns Hopkins All Children's Hospital, St. Petersburg

37205

Saint Thomas West Hospital and Research Institute, Nashville

40208

University of Louisville, Louisville

40241

Norton Cancer Institute, Louisville

44106

University Hospitals Cleveland Medical Center, Cleveland

44195

Cleveland Clinic Foundation, Cleveland

55102

United Children's Hospital St. Paul, Saint Paul

55455

University of Minnesota, Minneapolis

60611

Northwestern University, Chicago

63110

Washington University, St Louis

66160

University of Kansas Medical Center, Kansas City

72205

University of Arkansas for Medical Sciences, Little Rock

75390

University of Texas Southwestern Medical Center, Dallas

77030

MD Anderson, Houston

85013

Barrow Neurological Institute at Dignity Health St. Joseph's Hospital & Medical Center, Phoenix

92093

University of California, San Diego, La Jolla

92868

Children's Hospital of Orange County, Orange

06510

Yale University School of Medicine, New Haven

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Monteris Medical

INDUSTRY

NCT02392078 - Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System | Biotech Hunter | Biotech Hunter